aminosalicylic acid has been researched along with sulfasalazine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (34.48) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Chail, M; Dhaneshwar, SS; Naqvi, S; Patil, M; Vadnerkar, G | 1 |
| Bayram, E; Kufrevioglu, OI; Senturk, M; Supuran, CT | 1 |
| Bhatt, L; Dhaneshwar, SS; Gairola, N; Kadam, SS; Kandpal, M; Rathi, B; Vadnerkar, G | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Li, F; Wang, L; Wu, G; Zhao, Z; Zheng, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Codd, R; Gotsbacher, MP; Roth, L | 1 |
| Karmeli, F; Rachmilewitz, D; Schwartz, LW; Simon, PL | 1 |
| Bruckstein, AH | 1 |
| Karacsony, G; Nagy, F; Varro, V | 1 |
| Granger, DN; Grisham, MB; von Ritter, C | 1 |
| Ginsberg, AL | 1 |
| Edenius, C; Lindgren, JA; Sjöquist, B; Smedegård, G; Tornhamre, S | 1 |
| Friedman, G | 1 |
| Peskar, BM | 1 |
| Brown, JP; McGarraugh, GV; Onderdonk, AB; Parkinson, TM; Wingard, RE | 1 |
| SVARTZ, N | 1 |
| BEUTLER, E | 1 |
| HANNGREN, A; SVARTZ, N; ULLBERG, S | 1 |
| Couto, D; Fernandes, E; Freitas, M; Gomes, A; Lima, JL; Ribeiro, D | 1 |
| Nørgård, BM | 1 |
| Gaurav, V; Himanshu, R; Suneela, D | 1 |
| Habal, FM; Huang, VW | 1 |
| Dhaneshwar, SS | 1 |
| Bateman, BT; Brill, G; Bröms, G; Desai, RJ; Friedman, S; Hernandez-Diaz, S; Huybrechts, KF; Kim, SC; Wood, ME | 1 |
7 review(s) available for aminosalicylic acid and sulfasalazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New salicylate therapies for ulcerative colitis.
Topics: Administration, Oral; Administration, Rectal; Aminosalicylic Acid; Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1990 |
Topical salicylate therapy (4-ASA and 5-ASA enemas).
Topics: Administration, Topical; Aminosalicylic Acid; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Enema; Humans; Mesalamine; Sulfasalazine | 1989 |
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
[Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Mucosa; Leukotriene Antagonists; Mesalamine; Sulfasalazine | 1988 |
From conception to delivery: managing the pregnant inflammatory bowel disease patient.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Anti-Bacterial Agents; Azathioprine; Biological Products; Breast Feeding; Cyclosporine; Female; Fertility; Humans; Inflammatory Bowel Diseases; Maternal Exposure; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 2014 |
Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Clinical Trials as Topic; Colon; Fatty Acids, Omega-3; Heparin, Low-Molecular-Weight; Humans; Inflammatory Bowel Diseases; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine | 2014 |
1 trial(s) available for aminosalicylic acid and sulfasalazine
| Article | Year |
|---|---|
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
22 other study(ies) available for aminosalicylic acid and sulfasalazine
| Article | Year |
|---|---|
Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
Topics: Aminosalicylic Acids; Animals; Colitis; Colon; Drug Delivery Systems; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Liver; Pancreas; Prodrugs; Rats; Ulcer | 2009 |
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Topics: Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cytosol; Humans; Inhibitory Concentration 50; Molecular Structure; Salicylic Acid; Structure-Activity Relationship | 2008 |
Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Animals; Arthritis; Colitis; Colon; Female; Inflammatory Bowel Diseases; Male; Peroxidase; Prodrugs; Rats; Rats, Wistar; Ulcer | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
Topics: Animals; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Glucosides; Male; Molecular Structure; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2016 |
Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors.
Topics: Chromatography, Affinity; Coordination Complexes; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imino Acids; Metalloproteins; Metals, Heavy; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2020 |
Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis; Colon; Disease Models, Animal; Humans; Interleukin-1; Male; Mesalamine; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine | 1992 |
Experience with topical administration of 4-aminosalicylic acid in ulcerative colitis.
Topics: Administration, Topical; Aminosalicylic Acid; Aminosalicylic Acids; Colitis; Colon; Enema; Humans; Intestinal Mucosa; Recurrence; Sulfasalazine | 1989 |
Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Dapsone; Ileitis; Intestinal Absorption; Intestinal Mucosa; Mesalamine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine | 1989 |
Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Aminosalicylic Acid; Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukocytes; Leukotriene B4; Lipoxygenase; Mesalamine; Prostaglandin-Endoperoxide Synthases; Sulfapyridine; Sulfasalazine; Zymosan | 1989 |
A polymeric drug for treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acid; Animals; Biotransformation; Colitis, Ulcerative; Guinea Pigs; Intestines; Polymers; Salicylates; Sulfapyridine; Sulfasalazine | 1983 |
THE IMPORTANCE OF AUTORADIOGRAPHIC METHODS FOR STUDIES OF THE TISSUE AFFINITY OF DIFFERENT DRUGS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Autoradiography; Azo Compounds; Connective Tissue; Intestines; Joints; Metabolism; Mice; Pyridines; Research; Sulfanilamide; Sulfanilamides; Sulfasalazine; Sulfonamides | 1964 |
DRUG-INDUCED BLOOD DYSCRASIAS. III. HEMOLYTIC ANEMIA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hemolytic; Black People; Drug Hypersensitivity; Glucosephosphate Dehydrogenase Deficiency; Glucosephosphates; Humans; Naphthalenes; Nitrofurantoin; Sulfamethoxypyridazine; Sulfasalazine; Sulfones; Toxicology | 1964 |
CONTINUED AUTORADIOGRAPHIC STUDIES ON DRUG AFFINITY FOR THE INTESTINAL WALL AND OTHER TISSUES.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Intestines; Mice; Research; Sulfasalazine | 1964 |
Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine.
Topics: Aminosalicylic Acid; Hydrogen Peroxide; Molecular Structure; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfapyridine; Sulfasalazine; Superoxides | 2010 |
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acid; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Confidence Intervals; Crohn Disease; Denmark; Female; Humans; Immunosuppressive Agents; Mercaptopurine; Odds Ratio; Perinatal Care; Pharmacoepidemiology; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Registries; Sulfasalazine; Surveys and Questionnaires; Young Adult | 2011 |
Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach.
Topics: Aminosalicylic Acid; Animals; Azo Compounds; Colitis; Colon; Drug Design; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Models, Animal; Prodrugs; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2013 |
The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
Topics: Aminosalicylic Acid; Colitis, Ulcerative; Crohn Disease; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Pregnancy; Pregnancy Complications; Sulfasalazine; Sweden; Tumor Necrosis Factor Inhibitors; United States | 2021 |